المؤلفون: Brown F., Yii M., Kerr P.G., Polkinghorne K.R., Mulley W., Shrestha S., Kanellis J., Korman T.

مصطلحات الفهرس: adult, aged, antibiotic prophylaxis, antibiotic sensitivity, antibiotic therapy, antibody mediated rejection, article, brain abscess, brain edema, continuous ambulatory peritoneal dialysis, cytomegalovirus infection/dt [Drug Therapy], cytomegalovirus infection/pc [Prevention], cytomegalovirus pneumonia/dt [Drug Therapy], drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], female, frontal lobe, histopathology, hospital readmission, human, hyperkalemia/si [Side Effect], kidney graft rejection/dt [Drug Therapy], kidney graft rejection/pc [Prevention], kidney graft rejection/th [Therapy], kidney transplantation, kidney tubule acidosis/si [Side Effect], lung aspergillosis/dt [Drug Therapy], lung infection, ceftriaxone/dt [Drug Therapy], ceftriaxone/iv [Intravenous Drug Administration], cotrimoxazole/ae [Adverse Drug Reaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/po [Oral Drug Administration], ganciclovir/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], linezolid, meropenem/cb [Drug Combination], meropenem/dt [Drug Therapy], meropenem/iv [Intravenous Drug Administration], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], minocycline, moxifloxacin, mycophenolate mofetil/cb [Drug Combination], mycophenolate mofetil/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], valganciclovir/cb [Drug Combination], valganciclovir/dt [Drug Therapy], valganciclovir/po [Oral Drug Administration], voriconazole/dt [Drug Therapy], cytomegalovirus pneumonia, Nocardia nova, Nocardia veterana, pulmonary nocardiosis, virus pneumonia/dt [Drug Therapy], major clinical study, male, middle aged, Nocardia, Nocardia asteroides, nocardiosis/di [Diagnosis], nocardiosis/dt [Drug Therapy], nonhuman, plasmapheresis, pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], priority journal, respiratory failure/th [Therapy], retrospective study, single drug dose, stereotactic biopsy, amikacin, amoxicillin plus clavulanic acid, ceftriaxone/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39907
Nephrology
Click here for full text options
LibKey Link

المؤلفون: Brown F., Yii M., Kerr P.G., Polkinghorne K.R., Mulley W., Shrestha S., Kanellis J., Korman T.

مصطلحات الفهرس: adult, aged, antibiotic prophylaxis, antibiotic sensitivity, antibiotic therapy, antibody mediated rejection, article, brain abscess, brain edema, continuous ambulatory peritoneal dialysis, cytomegalovirus infection/dt [Drug Therapy], cytomegalovirus infection/pc [Prevention], cytomegalovirus pneumonia/dt [Drug Therapy], drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], female, frontal lobe, histopathology, hospital readmission, human, hyperkalemia/si [Side Effect], kidney graft rejection/dt [Drug Therapy], kidney graft rejection/pc [Prevention], kidney graft rejection/th [Therapy], kidney transplantation, kidney tubule acidosis/si [Side Effect], lung aspergillosis/dt [Drug Therapy], lung infection, ceftriaxone/dt [Drug Therapy], ceftriaxone/iv [Intravenous Drug Administration], cotrimoxazole/ae [Adverse Drug Reaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/po [Oral Drug Administration], ganciclovir/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], linezolid, meropenem/cb [Drug Combination], meropenem/dt [Drug Therapy], meropenem/iv [Intravenous Drug Administration], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], minocycline, moxifloxacin, mycophenolate mofetil/cb [Drug Combination], mycophenolate mofetil/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], valganciclovir/cb [Drug Combination], valganciclovir/dt [Drug Therapy], valganciclovir/po [Oral Drug Administration], voriconazole/dt [Drug Therapy], cytomegalovirus pneumonia, Nocardia nova, Nocardia veterana, pulmonary nocardiosis, virus pneumonia/dt [Drug Therapy], major clinical study, male, middle aged, Nocardia, Nocardia asteroides, nocardiosis/di [Diagnosis], nocardiosis/dt [Drug Therapy], nonhuman, plasmapheresis, pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], priority journal, respiratory failure/th [Therapy], retrospective study, single drug dose, stereotactic biopsy, amikacin, amoxicillin plus clavulanic acid, ceftriaxone/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39907
Nephrology
LibKey Link

المؤلفون: Jenkin G.A., Korman T.M., Francis M., Woolley I., Webb B., Le Q., Cross G.B.

مصطلحات الفهرس: osteomyelitis/dt [Drug Therapy], Pneumocystis pneumonia/dt [Drug Therapy], Pneumocystis pneumonia/pc [Prevention], priority journal, review, treatment outcome, azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], cefalexin/cb [Drug Combination], cefalexin/dt [Drug Therapy], cefalexin/po [Oral Drug Administration], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], ciprofloxacin/cb [Drug Combination], ciprofloxacin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], efavirenz/cb [Drug Combination], efavirenz/dt [Drug Therapy], emtricitabine/cb [Drug Combination], emtricitabine/dt [Drug Therapy], rifampicin/cb [Drug Combination], rifampicin/dt [Drug Therapy], tenofovir/cb [Drug Combination], tenofovir/dt [Drug Therapy], adult, bone infection, case report, disease association, disease severity, human, Human immunodeficiency virus infection/dt [Drug Therapy], immune reconstitution inflammatory syndrome, infectious arthritis/dt [Drug Therapy], male, Medline, middle aged, mycobacteriosis/dt [Drug Therapy], Mycobacterium haemophilum, national health organization, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40769
International Journal of STD and AIDS
Click here for full text options
LibKey Link

المؤلفون: Jenkin G.A., Korman T.M., Francis M., Woolley I., Webb B., Le Q., Cross G.B.

مصطلحات الفهرس: osteomyelitis/dt [Drug Therapy], Pneumocystis pneumonia/dt [Drug Therapy], Pneumocystis pneumonia/pc [Prevention], priority journal, review, treatment outcome, azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], cefalexin/cb [Drug Combination], cefalexin/dt [Drug Therapy], cefalexin/po [Oral Drug Administration], cefazolin/cb [Drug Combination], cefazolin/dt [Drug Therapy], cefazolin/iv [Intravenous Drug Administration], ciprofloxacin/cb [Drug Combination], ciprofloxacin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], efavirenz/cb [Drug Combination], efavirenz/dt [Drug Therapy], emtricitabine/cb [Drug Combination], emtricitabine/dt [Drug Therapy], rifampicin/cb [Drug Combination], rifampicin/dt [Drug Therapy], tenofovir/cb [Drug Combination], tenofovir/dt [Drug Therapy], adult, bone infection, case report, disease association, disease severity, human, Human immunodeficiency virus infection/dt [Drug Therapy], immune reconstitution inflammatory syndrome, infectious arthritis/dt [Drug Therapy], male, Medline, middle aged, mycobacteriosis/dt [Drug Therapy], Mycobacterium haemophilum, national health organization, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40769
International Journal of STD and AIDS
LibKey Link

المؤلفون: Heloury Y., Leclair M.-D.

مصطلحات الفهرس: drug release, enuresis/dt [Drug Therapy], feedback system, flushing, human, incontinence, micturition, micturition disorder, neurogenic bowel, overactive bladder/dt [Drug Therapy], pelvic floor muscle training, postvoid residual urine volume, priority journal, review, side effect/si [Side Effect], sphincter, stress incontinence, urinary tract disease, urine incontinence/dt [Drug Therapy], urine incontinence/pc [Prevention], xerostomia/si [Side Effect], alfuzosin/do [Drug Dose], alfuzosin/pd [Pharmacology], alpha adrenergic receptor blocking agent/pd [Pharmacology], botulinum toxin A/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], methylphenidate, nitrofurantoin/cb [Drug Combination], nitrofurantoin/dt [Drug Therapy], oxybutynin/ae [Adverse Drug Reaction], oxybutynin/cm [Drug Comparison], oxybutynin/pr [Pharmaceutics], oxybutynin/pk [Pharmacokinetics], oxybutynin/pd [Pharmacology], placebo, propiverine/dt [Drug Therapy], tolterodine/cm [Drug Comparison], tolterodine/pr [Pharmaceutics], tolterodine/pk [Pharmacokinetics], tolterodine/pd [Pharmacology], trimethoprim/dt [Drug Therapy], trospium chloride/dt [Drug Therapy], trospium chloride/pd [Pharmacology], unclassified drug, dysfunctional elimination syndrome, extraordinary daytime urinary frequency, hinman syndrome, postvoid dribbling, doxazocin/do [Drug Dose], doxazocin/pd [Pharmacology], giggle incontinence/dt [Drug Therapy], antibiotic prophylaxis, anticholinergic effect, bladder contraction, bladder disease, bladder dysfunction, bladder filling, bladder instability/dt [Drug Therapy], constipation/si [Side Effect], detrusor muscle, disease association, disease severity, drug dose increase, drug efficacy, drug formulation, Review

URL: Click here for full text options
LibKey Link

المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
Click here for full text options
LibKey Link

المؤلفون: Craig S.

مصطلحات الفهرس: drug half life, drug intoxication/di [Diagnosis], drug intoxication/et [Etiology], drug solubility, electrocardiogram, follow up, heart arrhythmia/co [Complication], hemodialysis, hemofiltration, hemoperfusion, human, hypersensitivity reaction/di [Diagnosis], hypersensitivity reaction/si [Side Effect], hypotension/co [Complication], intensive care unit, nausea, nystagmus, peripheral neuropathy/si [Side Effect], peritoneal dialysis, plasmapheresis, priority journal, respiration depression/co [Complication], review, risk factor, seizure/co [Complication], seizure/dt [Drug Therapy], stomach emptying, stomach lavage, symptom, trigeminus neuralgia/dt [Drug Therapy], vomiting/dt [Drug Therapy], acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/it [Drug Interaction], activated carbon, anticonvulsive agent/ae [Adverse Drug Reaction], anticonvulsive agent/cb [Drug Combination], anticonvulsive agent/cr [Drug Concentration], anticonvulsive agent/do [Drug Dose], anticonvulsive agent/it [Drug Interaction], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], anticonvulsive agent/iv [Intravenous Drug Administration], anticonvulsive agent/po [Oral Drug Administration], anticonvulsive agent/pr [Pharmaceutics], anticonvulsive agent/pk [Pharmacokinetics], anticonvulsive agent/pd [Pharmacology], antiemetic agent/dt [Drug Therapy], antineoplastic agent/cb [Drug Combination], antineoplastic agent/it [Drug Interaction], azapropazone/cb [Drug Combination], azapropazone/it [Drug Interaction], benzodiazepine derivative/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/it [Drug Interaction], chlordiazepoxide/cb [Drug Combination], chlordiazepoxide/it [Drug Interaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], diazepam/cb [Drug Combination], diazepam/it [Drug Interaction], diltiazem/cb [Drug Combination], diltiazem/it [Drug Interaction], fluconazole/cb [Drug Combination], fluconazole/it [Drug Interaction], imipramine/cb [Drug Combination], imipramine/it [Drug Interaction], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], itraconazole/cb [Drug Combination], itraconazole/it [Drug Interaction], losartan/cb [Drug Combination], losartan/it [Drug Interaction], miconazole/cb [Drug Combination], miconazole/it [Drug Interaction], paroxetine/cb [Drug Combination], paroxetine/it [Drug Interaction], phenobarbital/dt [Drug Therapy], phenytoin/ae [Adverse Drug Reaction], phenytoin/ad [Drug Administration], phenytoin/cb [Drug Combination], phenytoin/cr [Drug Concentration], phenytoin/do [Drug Dose], phenytoin/to [Drug Toxicity], phenytoin/iv [Intravenous Drug Administration], phenytoin/po [Oral Drug Administration], phenytoin/pr [Pharmaceutics], phenytoin/pk [Pharmacokinetics], phenytoin/pd [Pharmacology], pyridoxine/cb [Drug Combination], pyridoxine/it [Drug Interaction], ranitidine/cb [Drug Combination], ranitidine/it [Drug Interaction], thioridazine/cb [Drug Combination], thioridazine/it [Drug Interaction], tolbutamide/cb [Drug Combination], tolbutamide/it [Drug Interaction], unindexed drug, valproic acid/cb [Drug Combination], valproic acid/it [Drug Interaction], verapamil/cb [Drug Combination], verapamil/it [Drug Interaction], vigabatrin/cb [Drug Combination], vigabatrin/it [Drug Interaction], viloxazine/cb [Drug Combination], viloxazine/it [Drug Interaction], QT prolongation, phenytoin/it [Drug Interaction], aspiration, behavior disorder/dt [Drug Therapy], bipolar disorder/dt [Drug Therapy], cerebellum atrophy/co [Complication], cerebellum atrophy/et [Etiology], cerebellum atrophy/si [Side Effect], clinical feature, coma, confusion, convulsion/dt [Drug Therapy], differential diagnosis, drug formulation, Review

URL: Click here for full text options
LibKey Link

المؤلفون: Heloury Y., Leclair M.-D.

مصطلحات الفهرس: drug release, enuresis/dt [Drug Therapy], feedback system, flushing, human, incontinence, micturition, micturition disorder, neurogenic bowel, overactive bladder/dt [Drug Therapy], pelvic floor muscle training, postvoid residual urine volume, priority journal, review, side effect/si [Side Effect], sphincter, stress incontinence, urinary tract disease, urine incontinence/dt [Drug Therapy], urine incontinence/pc [Prevention], xerostomia/si [Side Effect], alfuzosin/do [Drug Dose], alfuzosin/pd [Pharmacology], alpha adrenergic receptor blocking agent/pd [Pharmacology], botulinum toxin A/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], methylphenidate, nitrofurantoin/cb [Drug Combination], nitrofurantoin/dt [Drug Therapy], oxybutynin/ae [Adverse Drug Reaction], oxybutynin/cm [Drug Comparison], oxybutynin/pr [Pharmaceutics], oxybutynin/pk [Pharmacokinetics], oxybutynin/pd [Pharmacology], placebo, propiverine/dt [Drug Therapy], tolterodine/cm [Drug Comparison], tolterodine/pr [Pharmaceutics], tolterodine/pk [Pharmacokinetics], tolterodine/pd [Pharmacology], trimethoprim/dt [Drug Therapy], trospium chloride/dt [Drug Therapy], trospium chloride/pd [Pharmacology], unclassified drug, dysfunctional elimination syndrome, extraordinary daytime urinary frequency, hinman syndrome, postvoid dribbling, doxazocin/do [Drug Dose], doxazocin/pd [Pharmacology], giggle incontinence/dt [Drug Therapy], antibiotic prophylaxis, anticholinergic effect, bladder contraction, bladder disease, bladder dysfunction, bladder filling, bladder instability/dt [Drug Therapy], constipation/si [Side Effect], detrusor muscle, disease association, disease severity, drug dose increase, drug efficacy, drug formulation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30904
LibKey Link

المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
LibKey Link

المؤلفون: Craig S.

مصطلحات الفهرس: drug half life, drug intoxication/di [Diagnosis], drug intoxication/et [Etiology], drug solubility, electrocardiogram, follow up, heart arrhythmia/co [Complication], hemodialysis, hemofiltration, hemoperfusion, human, hypersensitivity reaction/di [Diagnosis], hypersensitivity reaction/si [Side Effect], hypotension/co [Complication], intensive care unit, nausea, nystagmus, peripheral neuropathy/si [Side Effect], peritoneal dialysis, plasmapheresis, priority journal, respiration depression/co [Complication], review, risk factor, seizure/co [Complication], seizure/dt [Drug Therapy], stomach emptying, stomach lavage, symptom, trigeminus neuralgia/dt [Drug Therapy], vomiting/dt [Drug Therapy], acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/it [Drug Interaction], activated carbon, anticonvulsive agent/ae [Adverse Drug Reaction], anticonvulsive agent/cb [Drug Combination], anticonvulsive agent/cr [Drug Concentration], anticonvulsive agent/do [Drug Dose], anticonvulsive agent/it [Drug Interaction], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], anticonvulsive agent/iv [Intravenous Drug Administration], anticonvulsive agent/po [Oral Drug Administration], anticonvulsive agent/pr [Pharmaceutics], anticonvulsive agent/pk [Pharmacokinetics], anticonvulsive agent/pd [Pharmacology], antiemetic agent/dt [Drug Therapy], antineoplastic agent/cb [Drug Combination], antineoplastic agent/it [Drug Interaction], azapropazone/cb [Drug Combination], azapropazone/it [Drug Interaction], benzodiazepine derivative/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/it [Drug Interaction], chlordiazepoxide/cb [Drug Combination], chlordiazepoxide/it [Drug Interaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], diazepam/cb [Drug Combination], diazepam/it [Drug Interaction], diltiazem/cb [Drug Combination], diltiazem/it [Drug Interaction], fluconazole/cb [Drug Combination], fluconazole/it [Drug Interaction], imipramine/cb [Drug Combination], imipramine/it [Drug Interaction], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], itraconazole/cb [Drug Combination], itraconazole/it [Drug Interaction], losartan/cb [Drug Combination], losartan/it [Drug Interaction], miconazole/cb [Drug Combination], miconazole/it [Drug Interaction], paroxetine/cb [Drug Combination], paroxetine/it [Drug Interaction], phenobarbital/dt [Drug Therapy], phenytoin/ae [Adverse Drug Reaction], phenytoin/ad [Drug Administration], phenytoin/cb [Drug Combination], phenytoin/cr [Drug Concentration], phenytoin/do [Drug Dose], phenytoin/to [Drug Toxicity], phenytoin/iv [Intravenous Drug Administration], phenytoin/po [Oral Drug Administration], phenytoin/pr [Pharmaceutics], phenytoin/pk [Pharmacokinetics], phenytoin/pd [Pharmacology], pyridoxine/cb [Drug Combination], pyridoxine/it [Drug Interaction], ranitidine/cb [Drug Combination], ranitidine/it [Drug Interaction], thioridazine/cb [Drug Combination], thioridazine/it [Drug Interaction], tolbutamide/cb [Drug Combination], tolbutamide/it [Drug Interaction], unindexed drug, valproic acid/cb [Drug Combination], valproic acid/it [Drug Interaction], verapamil/cb [Drug Combination], verapamil/it [Drug Interaction], vigabatrin/cb [Drug Combination], vigabatrin/it [Drug Interaction], viloxazine/cb [Drug Combination], viloxazine/it [Drug Interaction], QT prolongation, phenytoin/it [Drug Interaction], aspiration, behavior disorder/dt [Drug Therapy], bipolar disorder/dt [Drug Therapy], cerebellum atrophy/co [Complication], cerebellum atrophy/et [Etiology], cerebellum atrophy/si [Side Effect], clinical feature, coma, confusion, convulsion/dt [Drug Therapy], differential diagnosis, drug formulation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32212
LibKey Link

المؤلفون: Spelman D.W., Friedman N.D., Korman T.M., Fairley C.K., Franklin J.C.

مصطلحات الفهرس: data analysis, death, disease duration, drug potentiation, female, hospital infection/et [Etiology], human, immune deficiency, laboratory, male, medical record, prevalence, retrospective study, Stenotrophomonas maltophilia, aminoglycoside, antibiotic agent/dt [Drug Therapy], antibiotic agent/im [Intramuscular Drug Administration], antibiotic agent/iv [Intravenous Drug Administration], antibiotic agent/po [Oral Drug Administration], azathioprine, carbapenem, carbenicillin/cb [Drug Combination], carbenicillin/it [Drug Interaction], cefazolin, ceftazidime, cephalosporin, chloramphenicol, ciprofloxacin, corticosteroid, cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], cotrimoxazole/dt [Drug Therapy], cyclosporin, gentamicin, imipenem, latamoxef, minocycline/cb [Drug Combination], minocycline/it [Drug Interaction], minocycline/dt [Drug Therapy], rifampicin/cb [Drug Combination], rifampicin/it [Drug Interaction], rifampicin/dt [Drug Therapy], steroid, sulfamethoxazole, thymocyte antibody, ticarcillin, timentin/cb [Drug Combination], timentin/it [Drug Interaction], timentin/dt [Drug Therapy], tobramycin, trimethoprim, controlled study, carbenicillin/dt [Drug Therapy], cefalotin, adult, aged, antibiotic sensitivity, antibiotic therapy, article, Australia, bacteremia/di [Diagnosis], bacteremia/dt [Drug Therapy], bacteremia/et [Etiology], bacterium isolate, blood culture, central venous catheter, clinical article, clinical study, correlation analysis, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33025
LibKey Link

المؤلفون: Turnidge J.

مصطلحات الفهرس: priority journal, cotrimoxazole/ae [Adverse Drug Reaction], cotrimoxazole/cb [Drug Combination], sulfamethoxazole/ae [Adverse Drug Reaction], sulfamethoxazole/cb [Drug Combination], trimethoprim/ae [Adverse Drug Reaction], trimethoprim/cb [Drug Combination], nonhuman, Australia, bacterial infection/dt [Drug Therapy], blood toxicity/si [Side Effect], computer analysis, data analysis, drug mixture, human, letter, liver toxicity/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34460
Click here for full text options
LibKey Link

المؤلفون: Turnidge J.

مصطلحات الفهرس: priority journal, cotrimoxazole/ae [Adverse Drug Reaction], cotrimoxazole/cb [Drug Combination], sulfamethoxazole/ae [Adverse Drug Reaction], sulfamethoxazole/cb [Drug Combination], trimethoprim/ae [Adverse Drug Reaction], trimethoprim/cb [Drug Combination], nonhuman, Australia, bacterial infection/dt [Drug Therapy], blood toxicity/si [Side Effect], computer analysis, data analysis, drug mixture, human, letter, liver toxicity/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34460
Click here for full text options
LibKey Link